Previous history of COVID-19 infection and heart disease and receiving Remdesivir History of lung disease History of liver disease (such as hepatitis, cirrhosis) History of underlying diseases other than renal impairment that contribute to poor prognosis and increased mortality following coronary heart disease (eg, heart failure, active cancer, advanced diabetes with severe macrovascular and microvascular complications, previous stroke) Immunosuppressive use except in the field of kidney transplantation Prohibition of Ramdesivir (except low GFR)

Previous history of COVID-19 infection and heart disease and receiving Remdesivir History of lung disease History of liver disease (such as hepatitis, cirrhosis) History of underlying diseases other than renal impairment that contribute to poor prognosis and increased mortality following coronary heart disease (eg, heart failure, active cancer, advanced diabetes with severe macrovascular and microvascular complications, previous stroke) Immunosuppressive use except in the field of kidney transplantation Prohibition of Ramdesivir (except low GFR)